The Federal Trade Commission (FTC) has sent 28 warning letters to eyeglass prescribers warning them of potential violations of the FTC’s Ophthalmic Practice Rules, known as the Eyeglass Rule, which enables consumers to comparison shop for prescription eyeglasses.
The Federal Trade Commission (FTC) has sent warning letters to 20 more marketers warning them to stop making unsubstantiated claims that their products and therapies can prevent or treat COVID-19, the disease caused by the novel coronavirus.
After a public comment period, the Federal Trade Commission (FTC) has approved a final agreement with Sunday Riley Modern Skincare, LLC, and its CEO, Sunday Riley.
Claims by doTERRA International, LLC, in advertising for its doTERRA essential oils were challenged by S. C. Johnson & Son, Inc., maker of Glade home fragrances, with the National Advertising Division (NAD).
The National Advertising Division determined that Avadim Health, Inc., did not provide adequate substantiation for health claims for its Theraworx Relief for Muscle Cramps and Spasm Foam and Theraworx Relief for Joint Discomfort & Inflammation Foam.
The National Advertising Division (NAD) continues to be active with cases involving COVID-19 claims.
In a mixed decision, the National Advertising Division (NAD) found that One Home Brands, Inc., d/b/a Blueland provided adequate substantiation for claims that its cleaning tablet wrappers are biodegradable and compostable, but recommended that Blueland discontinue unqualified recyclability claims ...
Claims by BodyArmor Nutrition, LLC, for BodyArmor SuperDrink and BodyArmor Lyte sports drink were challenged by Stokely-Van Camp, Inc. (SVC), maker of Gatorade sports drinks, at the National Advertising Division (NAD).
The Federal Trade Commission (FTC) has been active in sending refunds to consumers who were allegedly victimized by false and misleading advertising and marketing campaigns.
In another case, the Federal Trade Commission (FTC) announced that it is sending checks totaling more than $76,000 to consumers who bought Isoprex, a purported “miracle” pain supplement marketed to older Americans nationwide.